As of January 22, 2025, GeneDx Holdings (WGS) has a market cap of $2.08 billion USD. According to our data, GeneDx Holdings is ranked No.4078 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $2.08 B |
-1.42%
|
Dec 31, 2024 | $2.11 B |
2,694.91%
|
Dec 29, 2023 | $75.55 M |
-68.43%
|
Dec 30, 2022 | $0.24 B |
-94.08%
|
Dec 31, 2021 | $4.04 B |
-59.60%
|
Dec 31, 2020 | $10.01 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
0.000 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Pacific Biosciences
PACB
|
$0.52 B |
0.000 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Personalis
PSNL
|
$0.48 B |
0.000 M
|
USA
|
CareDx
CDNA
|
$1.24 B |
-0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Veracyte
VCYT
|
$3.34 B |
-0.000 M
|
USA
|
Market Cap | = | WGS Stock Price | * | WGS Shares Outstanding |
= | $75.77 | * | 27.47 M | |
= | $2.08 B |